QurAlis
Zoe Simmons, Ph.D. is a Scientist II at QurAlis, where Zoe focuses on advancing models, tools, and therapeutics for a metabolic neurodegenerative disease characterized by the formation of Lafora bodies in the brain and peripheral tissues. Prior to QurAlis, Zoe worked as a Scientist I at the University of Kentucky, where Zoe completed their Ph.D. in Molecular & Cellular Biochemistry. Zoe holds a Bachelor of Science in Biology: Neuroscience from Stony Brook University.
QurAlis
1 followers
QurAlis is developing precision therapeutics for ALS, a terminal disease that causes muscle paralysis through degeneration of the motor system. They are digging deep into the root causes of the multiple sub-forms of this destructive disease and focus their programs on tackling specific disease-causing mechanisms.